Seizures after alendronate

Journal of the Royal Society of Medicine

Volumn 95, Issue 12, 2002, Pages 615-616

  MacIsaac, Richard J ^a   Seeman, Ego ^a   Jerums, George ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM CARBONATE; ERGOCALCIFEROL; PHENYTOIN;

AGED; ARTICLE; BONE DENSITY; BONE MINERAL; CASE REPORT; FEMALE; HUMAN; HYPOCALCEMIA; MENINGIOMA; OSTEOPOROSIS; SECONDARY HYPERPARATHYROIDISM; SEIZURE; VITAMIN D DEFICIENCY;

EID: 0036901570     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1258/jrsm.95.12.615     Document Type: Article

References (6)

1. Harris ST, Gertz BJ, Genant HK, et al. The effect of short-term treatment with alendronate on vertebral density and biochemical markers of bone remodelling in early postmenopausal women. J Clin Endocrinol Metab 1993;76:1399-406
2. Schussheim DH, Jacobs TP, Silverberg SJ. Hypocalcemia associated with alendronate. Ann Intern Med 1999;130:329
3. Kashyap AS, Kashyap S. Hypoparathyroidism unmasked by alendronate. Postgrad Med J 2000;76:417-19
4. Stuckey BGA, Lim EM, Kent GW, et al. Bisphosphonate therapy for Paget's disease in a patient with hypoparathyroidism: Profound hypocalcemia, rapid response, and prolonged remission. J Bone Miner Res 2000;16:1719-23
5. Compston JE. Vitamin D deficiency: Time for action. BMJ 1998;317:1466-77
6. Heller HJ, Sakhaee K. Anticonvulsant-induced bone disease. A plea for monitoring and treatment. Arch Neurol 2001;58:1352-3